Inotiv, Inc (NOTV) Stock

About Inotiv, Inc

Inotiv, Inc. is a specialized life sciences company that delivers preclinical research and development solutions to the biopharmaceutical, chemical, and medical technology sectors. Additionally, it manufactures and supplies advanced analytical instrumentation for drug development and contract research organizations (CROs). The company's operations are divided into two primary divisions: Contract Research Services (CRS): This segment provides a comprehensive suite of services, including early-stage pharmacological screening, non-clinical safety assessments, formulation development support, regulatory compliance, and quality control testing. Its offerings also encompass analytical method development and validation; in-depth drug metabolism, bioanalysis, and pharmacokinetics (DMPK) studies to precisely quantify drug and metabolite concentrations in complex biological matrices; specialized in vivo sampling for continuous biological monitoring; stability testing for both preclinical and clinical formulations; non-clinical toxicology and pathology evaluations; and secure, climate-controlled archiving for client data and biological samples. Research Products: This division focuses on the design, manufacturing, and commercialization of specialized in vivo sampling systems, complete with accessories, consumables, training, and qualification support. It also offers physiological monitoring tools and a range of analytical instrumentation, particularly liquid chromatography and electrochemistry platforms and their associated accessories. A notable product line includes the Culex family of automated in vivo sampling and dosing instrumentation. Inotiv maintains a significant global footprint, serving clients across the United States, broader North America, the Pacific Rim, Europe, and other international markets. The company recently partnered with BioVaxys for preclinical toxicity studies related to its Covid-T Immunodiagnostic program. Founded in 1974, the company was initially known as Bioanalytical Systems, Inc. before rebranding as Inotiv, Inc. in March 2021. Its headquarters are located in West Lafayette, Indiana.

Inotiv, Inc is led by CEO Robert W. Leasure Jr., employs 1,977 people, headquartered in US, publicly traded since 1997.

Inotiv, Inc (NOTV) stock trades at $0.27 with a market capitalization of $9.42M. The stock is valued at a price-to-earnings (P/E) ratio of -0.14, price-to-book of 0.07, price-to-sales of 0.02. Over the past 52 weeks the stock has ranged between $0.02 and $2.44, and currently trades 88.9% below its 52-week high.

On profitability, Inotiv, Inc generates a return on equity (ROE) of -50.74%, return on capital employed of -22.79%, an operating margin of -6.04%, a net profit margin of -17.14%.

Official website: www.inotivco.com